Request Trial
searching-questions
Ollyy / Shutterstock.com
20 June 2014Asia-PacificWolfgang Bublak and Yingkun Brunner

Utility models: searching questions

China has, historically, been comparatively weak in the fields of science and technology innovation, not least in the life sciences. The inventions and creations of many small and medium-sized enterprises were of a low standard technically, and the majority were of limited importance.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Asia-Pacific
Generic rival blocked as AZ defends diabetes stronghold
17 February 2026   With a UK defeat still fresh, the Swedish-British drugmaker has secured breathing room in Australia—but a validity battle and key question of patent law looms at trial.
Asia-Pacific
Australia boutique hires experienced life sciences litigator
23 February 2023   New recruit joins from DLA Piper and will head up firm’s litigation team | Previously worked on Pfizer v Samsung Bioepis, Jusand v Rattlejack & Murray Engineering, and Pfizer v Sandoz | Follows prosecutor Chris Vindurampulle who joined in October last year.
Asia-Pacific
Australian court rejects Boehringer opposition bid against MSD unit’s anti-parasitic drug patent
24 May 2022   The Federal Court of Australia has refused an appeal request in a decade-long case brought by Boehringer Ingelheim Animal Health against MSD subsidiary, Intervet International.


Editor's picks

Novo Nordisk takes on Hims & Hers after $49 pill ‘turnaround’
Americas
Novo Nordisk takes on Hims & Hers after $49 pill ‘turnaround’
10 February 2026

Editor's picks

Americas
Novo Nordisk takes on Hims & Hers after $49 pill ‘turnaround’
10 February 2026
Americas
The quantum advantage: IP considerations for the next generation of life sciences innovation
27 January 2026
Europe
Final call: Who are the world’s best in-house counsel?
16 January 2026
Americas
Bayer enters COVID-19 vaccine row with three suits against major drugmakers
8 January 2026
Americas
SCOTUS shuts the door on Entresto ‘after-arising technology’ review
17 December 2025
Europe
Abbott appeals ‘baffling’ decision in glucose monitoring device feud
16 December 2025

More features

Could everyday hospital equipment be the next defence against counterfeit medicines?
Danaher moves to acquire Masimo in $9.9bn deal
Generic rival blocked as AZ defends diabetes stronghold
AstraZeneca partners with Chinese firm ahead of next obesity race
Rooted in rights: Lessons from plant patent infringement and invalidity cases
Chinese biotech strikes billion dollar deal in nextgen cancer race
How AI will be shaped by legal and regulatory developments in 2026
Key EU and UK regulatory changes to watch for in 2026